| Title |
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
|
|---|---|
| Published in |
Pharmaceutical Research, November 2010
|
| DOI | 10.1007/s11095-010-0313-5 |
| Pubmed ID | |
| Authors |
Jean-Paul Pirnay, Daniel De Vos, Gilbert Verbeken, Maia Merabishvili, Nina Chanishvili, Mario Vaneechoutte, Martin Zizi, Geert Laire, Rob Lavigne, Isabelle Huys, Guy Van den Mooter, Angus Buckling, Laurent Debarbieux, Flavie Pouillot, Joana Azeredo, Elisabeth Kutter, Alain Dublanchet, Andrzej Górski, Revaz Adamia |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| United Kingdom | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 298 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | <1% |
| Ireland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 293 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 51 | 17% |
| Student > Master | 44 | 15% |
| Student > Ph. D. Student | 43 | 14% |
| Researcher | 37 | 12% |
| Student > Postgraduate | 12 | 4% |
| Other | 47 | 16% |
| Unknown | 64 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 83 | 28% |
| Biochemistry, Genetics and Molecular Biology | 49 | 16% |
| Immunology and Microbiology | 32 | 11% |
| Medicine and Dentistry | 25 | 8% |
| Chemistry | 8 | 3% |
| Other | 28 | 9% |
| Unknown | 73 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2024.
All research outputs
#4,499,159
of 25,837,817 outputs
Outputs from Pharmaceutical Research
#463
of 3,104 outputs
Outputs of similar age
#20,045
of 113,220 outputs
Outputs of similar age from Pharmaceutical Research
#9
of 34 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,104 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 113,220 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.